Brief: Aura Biosciences Reports Q1 2022 Results
12/05/2022 21:21
May 12 (Reuters) - Aura Biosciences Inc AURA.O :
* AURA BIOSCIENCES REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CLINICAL DEVELOPMENT AND OPERATIONAL HIGHLIGHTS
* AURA BIOSCIENCES INC- AS OF MARCH 31, 2022, AURA HAD CASH
AND
CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALING $133.3
MILLION
* AURA BIOSCIENCES INC- BELIEVES ITS CURRENT CASH AND CASH
EQUIVALENTS AND MARKETABLE SECURITIES ARE SUFFICIENT TO FUND ITS
OPERATIONS INTO 2024
* AURA BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.44
Source text for Eikon: ID:nBw5wT84La
Further company coverage: AURA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aura Biosciences
See all newsBrief: Aura Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Aura Biosciences - May Offer Securities Up To $500 Million Aggregate
Brief: Aura Biosciences Reports Second Quarter 2026 Financial Results And Recent Business Highlights
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Aura Biosciences Q1 net loss widens on higher R&D costs